Annals of surgical oncologyHumansLiver NeoplasmsColorectal NeoplasmsFloxuridineMale
Hepatic Recurrence Rate Based on Extent of Adjuvant Floxuridine Exposure After Resection of Colorectal Liver Metastases.
Omar A Zaki, Raja R Narayan, Rami Srouji, Thomas Boerner, Kenneth Seier, Mithat Gönen, Louise C Connell, Andrea Cercek, Nancy E Kemeny, Vinod P Balachandran, Jeffrey A Drebin, Kevin C Soares, T Peter Kingham, Alice C Wei, William R Jarnagin
Published: 202610.1245/s10434-025-18568-z
Abstract
BACKGROUND: Hepatic artery infusion (HAI) chemotherapy improves hepatic recurrence rates and survival for patients with colorectal liver metastases (CRLM) in the adjuvant setting. Dose reductions of HAI floxuridine (FUDR) are common due to hepatotoxi…
Preview only. Read the full abstract at the source